Report Detail

Request for Sample of this report

Pharma & Healthcare Global Narcotic (Opioid) Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514021
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
According to our (Global Info Research) latest study, the global Narcotic (Opioid) Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Narcotic (Opioid) Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Narcotic (Opioid) Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Narcotic (Opioid) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Narcotic (Opioid) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Purdue Pharma, Mallinckrodt and Amneal Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Narcotic (Opioid) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Market segment by Application
Pain Relief Application
Anesthesia Application
Market segment by players, this report covers
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Narcotic (Opioid) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Narcotic (Opioid) Drugs, with revenue, gross margin and global market share of Narcotic (Opioid) Drugs from 2018 to 2023.
Chapter 3, the Narcotic (Opioid) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Narcotic (Opioid) Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Narcotic (Opioid) Drugs.
Chapter 13, to describe Narcotic (Opioid) Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Narcotic (Opioid) Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Narcotic (Opioid) Drugs by Type
    • 1.3.1 Overview: Global Narcotic (Opioid) Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Narcotic (Opioid) Drugs Consumption Value Market Share by Type in 2022
    • 1.3.3 Codeine
    • 1.3.4 Fentanyl
    • 1.3.5 Hydrocodone
    • 1.3.6 Hydromorphone
    • 1.3.7 Meperidine
    • 1.3.8 Methadone
    • 1.3.9 Others
  • 1.4 Global Narcotic (Opioid) Drugs Market by Application
    • 1.4.1 Overview: Global Narcotic (Opioid) Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pain Relief Application
    • 1.4.3 Anesthesia Application
  • 1.5 Global Narcotic (Opioid) Drugs Market Size & Forecast
  • 1.6 Global Narcotic (Opioid) Drugs Market Size and Forecast by Region
    • 1.6.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Narcotic (Opioid) Drugs Market Size by Region, (2018-2029)
    • 1.6.3 North America Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
    • 1.6.6 South America Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Narcotic (Opioid) Drugs Product and Solutions
    • 2.1.4 Pfizer Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Narcotic (Opioid) Drugs Product and Solutions
    • 2.2.4 Teva Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Teva Recent Developments and Future Plans
  • 2.3 Purdue Pharma
    • 2.3.1 Purdue Pharma Details
    • 2.3.2 Purdue Pharma Major Business
    • 2.3.3 Purdue Pharma Narcotic (Opioid) Drugs Product and Solutions
    • 2.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Purdue Pharma Recent Developments and Future Plans
  • 2.4 Mallinckrodt
    • 2.4.1 Mallinckrodt Details
    • 2.4.2 Mallinckrodt Major Business
    • 2.4.3 Mallinckrodt Narcotic (Opioid) Drugs Product and Solutions
    • 2.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Mallinckrodt Recent Developments and Future Plans
  • 2.5 Amneal Pharma
    • 2.5.1 Amneal Pharma Details
    • 2.5.2 Amneal Pharma Major Business
    • 2.5.3 Amneal Pharma Narcotic (Opioid) Drugs Product and Solutions
    • 2.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Amneal Pharma Recent Developments and Future Plans
  • 2.6 Collegium
    • 2.6.1 Collegium Details
    • 2.6.2 Collegium Major Business
    • 2.6.3 Collegium Narcotic (Opioid) Drugs Product and Solutions
    • 2.6.4 Collegium Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Collegium Recent Developments and Future Plans
  • 2.7 Johnson & Johnson
    • 2.7.1 Johnson & Johnson Details
    • 2.7.2 Johnson & Johnson Major Business
    • 2.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Product and Solutions
    • 2.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Narcotic (Opioid) Drugs Product and Solutions
    • 2.8.4 Merck Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Merck Recent Developments and Future Plans
  • 2.9 Mylan
    • 2.9.1 Mylan Details
    • 2.9.2 Mylan Major Business
    • 2.9.3 Mylan Narcotic (Opioid) Drugs Product and Solutions
    • 2.9.4 Mylan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Mylan Recent Developments and Future Plans
  • 2.10 Hikma Pharmaceuticals
    • 2.10.1 Hikma Pharmaceuticals Details
    • 2.10.2 Hikma Pharmaceuticals Major Business
    • 2.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
    • 2.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Hikma Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Sun Pharma
    • 2.11.1 Sun Pharma Details
    • 2.11.2 Sun Pharma Major Business
    • 2.11.3 Sun Pharma Narcotic (Opioid) Drugs Product and Solutions
    • 2.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Sun Pharma Recent Developments and Future Plans
  • 2.12 Endo Pharmaceuticals
    • 2.12.1 Endo Pharmaceuticals Details
    • 2.12.2 Endo Pharmaceuticals Major Business
    • 2.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
    • 2.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Endo Pharmaceuticals Recent Developments and Future Plans
  • 2.13 Allergan
    • 2.13.1 Allergan Details
    • 2.13.2 Allergan Major Business
    • 2.13.3 Allergan Narcotic (Opioid) Drugs Product and Solutions
    • 2.13.4 Allergan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Narcotic (Opioid) Drugs Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Narcotic (Opioid) Drugs by Company Revenue
    • 3.2.2 Top 3 Narcotic (Opioid) Drugs Players Market Share in 2022
    • 3.2.3 Top 6 Narcotic (Opioid) Drugs Players Market Share in 2022
  • 3.3 Narcotic (Opioid) Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Narcotic (Opioid) Drugs Market: Region Footprint
    • 3.3.2 Narcotic (Opioid) Drugs Market: Company Product Type Footprint
    • 3.3.3 Narcotic (Opioid) Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Narcotic (Opioid) Drugs Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Narcotic (Opioid) Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Narcotic (Opioid) Drugs Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
  • 6.2 North America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
  • 6.3 North America Narcotic (Opioid) Drugs Market Size by Country
    • 6.3.1 North America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
    • 6.3.2 United States Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
  • 7.2 Europe Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
  • 7.3 Europe Narcotic (Opioid) Drugs Market Size by Country
    • 7.3.1 Europe Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 7.3.3 France Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Region (2018-2029)
    • 8.3.2 China Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 8.3.5 India Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
  • 9.2 South America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
  • 9.3 South America Narcotic (Opioid) Drugs Market Size by Country
    • 9.3.1 South America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Narcotic (Opioid) Drugs Market Drivers
  • 11.2 Narcotic (Opioid) Drugs Market Restraints
  • 11.3 Narcotic (Opioid) Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Narcotic (Opioid) Drugs Industry Chain
  • 12.2 Narcotic (Opioid) Drugs Upstream Analysis
  • 12.3 Narcotic (Opioid) Drugs Midstream Analysis
  • 12.4 Narcotic (Opioid) Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Narcotic (Opioid) Drugs. Industry analysis & Market Report on Narcotic (Opioid) Drugs is a syndicated market report, published as Global Narcotic (Opioid) Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Narcotic (Opioid) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo